Drug companies have done discontinuation trials where they stop the medicine and see what happens, and in those, most people regained most of their weight and reversed the metabolic improvements that they made. Scripps study shows promise for reducing dosing After hearing anecdotes from patients who had experimented with their dosage, Dr
If alcohol becomes less appealing, those deeper needs may still be there
(2020) Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine
The combination is the most popular growth hormone stack and the best starting point for anyone interested in GH peptides
It works as a central nervous system depressant by reducing muscle hyperactivity

Baseline bloodwork CBC, CRP, ferritin, IL-6, cortisol AM, metabolic panel, thyroid function Cardiovascular assessment heart rate variability, orthostatic vitals if POTS is suspected Gut health markers stool testing, zonulin, calprotectin if GI symptoms are prominent Mitochondrial function proxies lactate, organic acids panel if PEM is a primary complaint From there, a typical protocol might be structured as: Phase 1 (Weeks 16): Immune and gut foundation Thymosin Alpha-1: 1.6 mg subcutaneous, twice weekly BPC-157: 250500 mcg daily, route determined by predominant symptom (oral for gut, injectable for systemic) Phase 2 (Weeks 412): Tissue repair and cardiovascular recovery TB-500: 2.02.5 mg subcutaneous, twice weekly Continue BPC-157 as indicated Phase 3 (Weeks 816): Maintenance and metabolic support Taper or pulse doses based on clinical response Add mitochondrial support if fatigue persists (see: Mitochondrial Peptides and Insulin Resistance) These are illustrative dosing ranges based on clinical research and published protocols
